Titan Pharmaceuticals
TTNP
$6.88
Share price
-2.55%
Change (1 day)
805.26%
Change (1 year)
Categories
Titan Pharmaceuticals (TTNP) - Total debt
Total debt on the balance sheet as of December 2023 : $0.56 M
According to Titan Pharmaceuticals 's latest financial reports the company's total debt is $0.56 M. A company’s total debt is the sum of all current and non-current debts.
Titan Pharmaceuticals - Total debt on balance sheet (from 2009 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.18 M | -37.46% |
| 2021-12-31 | $0.29 M | -63.04% |
| 2020-12-31 | $0.8 M | -81.78% |
| 2019-12-31 | $4.44 M | 2.94% |
| 2018-12-31 | $4.31 M | -34.48% |
| 2017-12-31 | $6.58 M | |
| 2013-12-31 | $N/A | -100% |
| 2012-12-31 | $11.86 M | -3.21% |
| 2011-12-31 | $12.25 M | 68.54% |
| 2010-12-31 | $7.27 M | 149.74% |
| 2009-12-31 | $2.91 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 5,191,404.42% | 🇺🇸 USA |
 Novartis NVS | $27.28 B | 4,828,926.55% | 🇨🇭 Switzerland |
 Vanda Pharmaceuticals VNDA | $9.4 M | 1,564.42% | 🇺🇸 USA |
 Repligen
RGEN | $0.71 B | 125,883.01% | 🇺🇸 USA |
 MediciNova MNOV | $0.21 M | -61.78% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $2.54 M | 349.91% | 🇺🇸 USA |